There's a lot of tips and tricks to get the best 3D print possible, and one of the most useful you may not have heard of are ...

News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to ...

News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to 16.6% weight loss with survodutide, a novel glucagon/GLP ...

United Nations resolution passes with 120 votes in favour of truce. This blog is now closed ...

If you travel deep into the New Right, what you find at the moment is a constant yearning for something very old. Not just a ...

Company announcement No. 21 / 2026Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and ...

Following in the footsteps of shows like The Twilight Zone, animation has taken advantage of the anthology format to deliver ...

Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, ...

News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to 16.6% weight loss with survodutide, a novel glucagon/GLP ...

Matt Mande and Gregory C. Allen provide a detailed overview Maven Smart System, the AI-powered software platform that has ...

Affirm Holdings, Inc. ( AFRM) 2026 Evercore Global TMT Conference June 3, 2026 1:50 PM EDT Okay. Thanks. We're going to get started here with Affirm, Rob O'Hare, CFO; Adam Frisch from Evercore ISI ...

Japan has had enough of being a ‘spy paradise’: lacking key elements of intelligence capability and enduring society-wide ...